Family · Pharmaceutical analytical standards
Dabigatran
An oral anticoagulant that directly inhibits thrombin, approved in Europe in 2008. It is given as a prodrug, dabigatran etexilate, which the body converts into the active form. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was the first of the new oral anticoagulants to get a specific antidote, idarucizumab, an antibody that neutralises it within minutes.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
